release 2d nmr software version 12.01 (ACD Labs Inc)
90
Structured Review
ACD Labs Inc
release 2d nmr software version 12.01
Release 2d Nmr Software Version 12.01, supplied by ACD Labs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+2d+nmr+software+version+12%2E01/1d+and+2d+nmr+processor+version+9/pm35635949-288-6-5
Average 90 stars, based on 1 article reviews
Release 2d Nmr Software Version 12.01, supplied by ACD Labs Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/release+2d+nmr+software+version+12%2E01/1d+and+2d+nmr+processor+version+9/pm35635949-288-6-5
Average 90 stars, based on 1 article reviews
release 2d nmr software version 12.01 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Nuclear Magnetic Resonance:Article Title: Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer. Article Snippet: A promising hydrazide based small molecule lead as a potent and selective histone deacetylase 3 (HDAC3) inhibitor has been developed from a small series of synthesized novel chemical entities.. The lead compound (4e) displayed high HDAC3 inhibitory potency (IC50 = 15.41 nM) and a minimum of 18-fold selectivity over other HDAC isoforms.. It also exhibited potent cytotoxicity against several cancer cell lines with minimal toxicity against normal cell lines tested. Software:Article Title: Selective inhibition of histone deacetylase 3 by novel hydrazide based small molecules as therapeutic intervention for the treatment of cancer. Article Snippet: A promising hydrazide based small molecule lead as a potent and selective histone deacetylase 3 (HDAC3) inhibitor has been developed from a small series of synthesized novel chemical entities.. The lead compound (4e) displayed high HDAC3 inhibitory potency (IC50 = 15.41 nM) and a minimum of 18-fold selectivity over other HDAC isoforms.. It also exhibited potent cytotoxicity against several cancer cell lines with minimal toxicity against normal cell lines tested. |